IDXX
Idexx Laboratories
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: IDXX
- PEG Ratio
IDXX currently has a PEG ratio reading of 1.56 as of Jun 22, 2026. Dividing the 39.83 PE ratio by the 25.5% earnings growth rate yields this valuation metric. When compared to the trailing four-quarter average of 2.15, IDXX's PEG ratio shows a 27% decrease.
IDXX PEG ratio history
A ten years lookback shows an average PEG ratio of 2.98 for Idexx Laboratories. Compared to historical data, IDXX's 1.56 PE to growth ratio represents a decline of 48%. The ten years high occurred in the Sep 2024 quarter at 8.46, reflecting maximum valuation relative to growth. The minimum was hit in the Dec 2018 quarter at 0.96, indicating optimal value relative to growth during that period.
Idexx Laboratories PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 2.3 | 51.37 | 22.3% |
| 2024 | 6.51 | 38.39 | 5.9% |
| 2023 | 2.17 | 54.58 | 25.2% |
| 2022 | N/A | 50.24 | -7.1% |
| 2021 | 2.67 | 75.34 | 28.2% |
| 2020 | 1.97 | 73.29 | 37.2% |
| 2019 | 3.62 | 52.54 | 14.5% |
| 2018 | 0.96 | 42.86 | 44.7% |
| 2017 | 2.42 | 52.13 | 21.5% |
| 2016 | 2.46 | 47.48 | 19.3% |
| 2015 | 2.57 | 35.23 | 13.7% |
| 2014 | 14.55 | 40.73 | 2.8% |
| 2013 | 3.23 | 30.05 | 9.3% |
| 2012 | 2.15 | 28.64 | 13.3% |
| 2011 | 1.65 | 26.91 | 16.3% |
Idexx Laboratories PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 1.61 | 41.01 | 25.5% |
| Dec 2025 | 2.3 | 51.37 | 22.3% |
| Sep 2025 | 2.34 | 50.23 | 21.5% |
| Jun 2025 | 2.34 | 44.25 | 18.9% |
| Mar 2025 | 8.18 | 38.46 | 4.7% |
| Dec 2024 | 6.51 | 38.39 | 5.9% |
| Sep 2024 | 8.46 | 48.25 | 5.7% |
| Jun 2024 | 6.93 | 47.81 | 6.9% |
| Mar 2024 | 2.14 | 51.77 | 24.2% |
| Dec 2023 | 2.17 | 54.58 | 25.2% |
| Sep 2023 | 1.8 | 44.12 | 24.5% |
| Jun 2023 | 2.46 | 52.7 | 21.4% |
| Mar 2023 | N/A | 59.53 | -2.9% |
| Dec 2022 | N/A | 50.24 | -7.1% |
| Sep 2022 | N/A | 40.93 | -10.3% |
IDXX average PEG ratio chart
Measured against past performance, IDXX's PEG ratio is below the 3, 5 and 10-year averages.
PEG comparison
Idexx Laboratories's PEG of 1.56 is above the Healthcare sector and the industry average. Compared to its Healthcare sector average of 0.55, Idexx Laboratories's PEG is 184% higher.
IDXX EPS growth
IDXX Price vs fair value
IDXX PEG vs peers
Compared to its peers, IDXX has a PEG ratio under stocks TMO and HSIC, while above WOOF's.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| WOOF Petco Health & Wellness Company Inc | 1.15 | $805.16M |
| IDXX Idexx Laboratories Inc | 1.56 | $43.1B |
| TMO Thermo Fisher Scientific Inc | 3.89 | $173.88B |
| HSIC Henry Schein Inc | 8.52 | $9.05B |
| NEOG Neogen Corp | N/A | $1.96B |
| ABT Abbott Laboratories | N/A | $155.54B |
Frequently asked questions
What is Idexx Laboratories's PEG ratio?
Based on Jun 22, 2026 data, IDXX carries a PEG ratio of 1.56.
What is the 3-year average PEG ratio for Idexx Laboratories (IDXX)?
IDXX has a 3-year average PEG ratio of 3.94.
What is the 5-year average PEG ratio for Idexx Laboratories (IDXX)?
IDXX has a 5-year average PEG ratio of 3.7.
What is the highest PEG ratio for IDXX?
IDXX's PEG ratio peaked at 8.46 during the Sep 2024 quarter - the highest in ten years.
How does the current PEG ratio for IDXX compare to its historical average?
Compared to the 10-year average, IDXX's PEG ratio is 48% lower.
How is IDXX's PEG ratio calculated (Idexx Laboratories PEG ratio formula)?
Computing the PEG ratio involves dividing the PE ratio by the company's EPS growth (YoY TTM). As of Jun 22, 2026, Idexx Laboratories has a P/E ratio of 39.83. Earnings grew at 25.5% over the TTM period ending Mar 2026. Applying the formula, this produces a price to earnings growth ratio of 1.56. PEG RATIO(1.56) = PE RATIO(39.83) / EPS GROWTH(25.5%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.